Work to Make a Difference – Michael Ullmann

SpreadLove In Organizations
SpreadLove In Organizations
Work to Make a Difference - Michael Ullmann
/

Being in healthcare is a privilege and a humbling responsibility; we impact lives. This is what Michael Ullman has done throughout his years at Johnson & Johnson from where he retired recently as Executive VP, General Counsel & Executive Committee Member. Leadership for Mike is grounded in humility, kindness, and optimism, it is above all a responsibility to other people. Hear Mike’s experience leading JNJ to deliver on covid vaccine that saved humanity during the pandemic, and his thoughts on ESG, Health Equity, social responsibility, and how to build high-performing teams to ensure we deliver on our purpose. As leaders, our job is not to be superstars but rather shine through others, through our people’s greatness. Kindness is underused in the world, create a culture that demands it, treat people with respect, trust them, empower them, and help them succeed.

“Kindness is underused. Create a culture that demands it.”

MEET OUR GUEST Michael Ullmann, (Retired) Executive Vice President, General Counsel & Executive Committee Member, Johnson & Johnson

Michael Ullmann retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security. 

As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike joined Johnson & Johnson in 1989 as a mergers & acquisitions attorney and held various management positions, including General Counsel of the Worldwide Medical Devices Group, before becoming the company’s General Counsel in 2012. Michael is a member of the Board of Directors of Americares and serves on the Columbia Law School Board of Visitors. 

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and…

Ask the Big Questions – Melanie Ivarsson

SpreadLove In Organizations
SpreadLove In Organizations
Ask the Big Questions - Melanie Ivarsson
/

In this episode, we chatted with Melanie Ivarsson, Chief Development Officer at Moderna, who led teams in times the world was anxiously waiting for them to deliver us a hope with Covid Vaccine… and they did. How did they achieve this? How do you lead in such unprecedented times? How do you ensure this sense of purpose continues to live today? Hear all about those stories and about Melanie’s biggest leadership learning throughout this once-in-a-lifetime experience: Enable others to be the best they can be, and don’t get in their way.

“Hang on to your true self.”

MEET OUR GUEST Melanie Ivarsson Chief Development Officer at Moderna.

Melanie Ivarsson is Senior Vice President, Chief Development Officer at Moderna, where she leads the Clinical Development Operations department. In this role Dr Ivarsson and her team deliver all clinical programs within the Moderna portfolio.

Melanie has more than 20 years of experience in the pharmaceutical industry. Prior to joining Moderna, she was Head of Global Clinical Operations, at Takeda (following the acquisition of Shire) and spent 9 years at Pfizer in Clinical Development. She also held roles within the early clinical development group at Eli Lilly.

After receiving her PhD from the University of Bristol, she completed postdoctoral research at Lund University and New York University. Dr Ivarsson also holds an Executive MBA from MIT Sloan School of Management.

EPISODE TRANSCRIPT: Melanie Ivarsson

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host today, having the pleasure to be joined by Melanie Ivarsson Chief Development Officer at Moderna. In this role Melanie leads the Clinical Development Operations department and delivers with her team all clinical programs within the Moderna portfolio. Prior to joining Moderna, she was Head of Global Clinical Operations at Takeda and spent 9 years at Pfizer in…

Take Risks to Impact the World – Marcello Damiani

SpreadLove In Organizations
SpreadLove In Organizations
Take Risks to Impact the World - Marcello Damiani
/

“What really matters is impact”. Marcello Damiani started with this statement, and we all know now the impact he and his teams at Moderna had on humanity over the past years. He has led teams through those times, delivered on an incredible challenge that became a hope, then a reality: Covid vaccines. Hear him share those stories, his learning, the role of leadership, digital, innovation… From the focus on purpose to the culture and mindset to deliver on it, Marcello gives us great words of wisdom as we continue to navigate times of uncertainty and change. Let’s “not be shy to take risks to impact the world”!

“A leader alone doesn’t serve any purpose”

MEET OUR GUEST Marcello Damiani, Chief Digital and Operational Excellence Officer at Moderna.

Marcello Damiani is the Chief Digital and Operational Excellence Officer at Moderna, where he builds the technology, processes, and digitization landscape required to advance a new class of medicines based on mRNA science. Marcello has a wealth of experience from both Tech and Life Science companies, with a true passion for making digital a reality. He has 20years experience working in the IT field, with the last 10years being spent in leadership roles for multinational companies in Europe and the USA. Prior to joining Moderna, he worked at diagnostics firm bioMérieux and before that at Motorola.

Marcello has a Master of Science degree in Information and Communication Systems Architecture from the University of Toulouse in France, and an Executive MBA through TRIUM.

Know What You Don’t Know – Susan Silbermann

SpreadLove In Organizations
SpreadLove In Organizations
Know What You Don't Know - Susan Silbermann
/

When we think of inspiring leaders, we remember those we learned from by watching how they did what they do. It is those we want to follow and be like. It is those who made us feel valued and heard, those who made us grow after each interaction even when it is an unpleasant conversation. Because people remember how they felt when you left the room, lead from a place of genuine care and love. Hear more from Susan Silbermann, her journey, and more of those incredible insights and learning she’s sharing with us.

“Ask the questions because you want to move the ball forward.”

MEET OUR GUEST Susan Silbermann, an accomplished, global senior business executive, with broad experience in healthcare across multiple geographies.

Curious by nature, Susan is an authentic and communicative leader who is adept at leading remote, diverse teams and who excels at working cross-functionally. This reputation extends to interactions in the policy, government affairs, and public health arenas.

She is a Board Director at HilleVax Inc (Comp Chair) and LianBio (NomGov Chair) and was recently appointed to the Board of Directors of IAVI, the International AIDS Vaccine Initiative. She is also a member of the board of Meet the Writers, a non-profit organization bringing together authors and students in low-income NYC public schools. Previously Susan served on numerous not-for-profit and NGO boards, including Gavi, the Vaccines Alliance (member of Governance Committee); Catalyst Inc; and the Council of the Americas. In March 2021, she stepped down as Vice-Chair of the President’s Council for Doing Business in Africa.

Before retiring from Pfizer last year, Susan led a then $8B revenue, 10,000 colleagues Emerging Markets division, and Pfizer’s internal Global COVID-19 Task Force, ensuring the safety and well-being of 75,000 employees, facilities, and medicine and vaccine supply chain. In her prior role, Susan was the Global President of Pfizer Vaccines, leading operations, commercial, and business development.

Susan is looking forward to whatever lies ahead — and looking backward doesn’t really lead you anywhere new, does it?